BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7169670)

  • 1. Non-H-2 restriction specificity of tumor-regressor mouse sera with regard to their activity to inhibit tumor cell transplantation.
    Egawa K; Kiyohara T; Tanino T
    Jpn J Exp Med; 1982 Oct; 52(5):255-60. PubMed ID: 7169670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regressor serum factor-dependent nonspecific killers in tumor-bearing mice.
    Tanino T; Egawa K
    Jpn J Exp Med; 1986 Aug; 56(4):163-8. PubMed ID: 3820734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
    Schirrmacher V
    Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
    Giovarelli M; Musiani P; Garotta G; Ebner R; Di Carlo E; Kim Y; Cappello P; Rigamonti L; Bernabei P; Novelli F; Modesti A; Coletti A; Ferrie AK; Lollini PL; Ruben S; Salcedo T; Forni G
    J Immunol; 1999 Nov; 163(9):4886-93. PubMed ID: 10528190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell-dependent nonspecific cytotoxicity induced by culture of mouse spleen cells against natural killer-insensitive tumor cells.
    Kiyohara T; Tanino T; Egawa K
    Jpn J Exp Med; 1982 Aug; 52(4):201-8. PubMed ID: 7176145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between foreign H-2-like antigens on MCG4 sarcoma and the in vivo rejection of this tumor by syngeneic and semisyngeneic mice.
    García-Olivares E; Torres MD; Gutiérrez F; Osorio C
    Rev Esp Fisiol; 1982 Mar; 38(1):9-12. PubMed ID: 7100610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonspecific cytotoxic cells induced in vivo and their comparison to culture-induced cytotoxic cells.
    Egawa K; Tanino T
    Jpn J Exp Med; 1982 Oct; 52(5):237-42. PubMed ID: 7169668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of tumor-associated embryonic substance from mouse ascites tumor cells: its cross-reactivity with human CEA.
    Saito M; Tanino T; Egawa K
    Jpn J Exp Med; 1980 Jun; 50(3):197-204. PubMed ID: 7431677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of murine tumors in adult mice by a combination of either avian sarcoma virus or human adenovirus and syngeneic mouse embryo cells.
    Takeuchi M; Nitta K
    Cancer Res; 1983 Jan; 43(1):328-32. PubMed ID: 6291756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic determination of the immune response in mice to cells of different histological type.
    Lavrovsky VA; Viksler VK; Yurchenko YA; Razvorotnev VA
    Immunology; 1979 Apr; 36(4):835-41. PubMed ID: 108209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
    Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
    Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of cell line-specific transplantation antigens from mouse ascites tumor cells.
    Tanino T; Saito M; Egawa K
    Gan; 1982 Apr; 73(2):299-307. PubMed ID: 7117755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing transplantation characteristics with serial in vivo passage of C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1978 Oct; 38(10):3264-8. PubMed ID: 688216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of "H-2K,D-like structures" on MM2 x mouse L cell hybrids. II. An "H-2Kd-like" structure on C3H-derived tumor.
    Kubota K; Manson LA
    Int J Cancer; 1983 May; 31(5):655-60. PubMed ID: 6852981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytolytic activity of murine CD4+ T cell clones correlates with IFN-gamma production in mouse strains having a BALB/c background.
    McKisic MD; Lancki DW; Fitch FW
    J Immunol; 1993 May; 150(9):3793-805. PubMed ID: 8097225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
    Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
    J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The induction of immunity against tumor cell transplantation with a complex of tumor cell surface substance and a serum component found in the tumor-regressor animals.
    Egawa K; Tanino T
    Int J Cancer; 1976 Jun; 17(6):725-9. PubMed ID: 947852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.